This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...